BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6340628)

  • 1. Mitomycin-associated renal failure. Case report and review.
    Hamner RW; Verani R; Weinman EJ
    Arch Intern Med; 1983 Apr; 143(4):803-7. PubMed ID: 6340628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 3. Silent renal microangiography after mitomycin C therapy.
    Poch E; González-Clemente JM; Torras A; Darnell A; Botey A; Revert L
    Am J Nephrol; 1990; 10(6):514-7. PubMed ID: 2127509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
    Simon P; Hervé JP; Ramée MP; Leroy JP; Ang KS; Leguy P; Vignoud J; Cledes J
    Nephrologie; 1982; 3(4):152-7. PubMed ID: 6818483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
    Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
    Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal disease after mitomycin C therapy.
    Hanna WT; Krauss S; Regester RF; Murphy WM
    Cancer; 1981 Dec; 48(12):2583-8. PubMed ID: 6796250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
    Ohashi N; Yonemura K; Sugiura T; Isozaki T; Togawa A; Fujigaki Y; Yamamoto T; Hishida A
    Am J Kidney Dis; 2003 Mar; 41(3):E10. PubMed ID: 12613003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic microangiopathy and chronic renal failure caused by mitomycin C in 4 women treated for breast cancer].
    Bayle F; Vialtel P; Bastrenta F; Swiercz P; Dechelette E; Pin I; Carpentier P; Mousseau M; Schaerer R; Couderc P; Cordonnier D
    Nouv Presse Med; 1982 Jun; 11(30):2300-1. PubMed ID: 6810311
    [No Abstract]   [Full Text] [Related]  

  • 17. Presentation and course of primary amyloidosis of the kidney.
    Ogg CS; Cameron JS; Williams DG; Turner DR
    Clin Nephrol; 1981 Jan; 15(1):9-13. PubMed ID: 7214752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of diabetic nephropathy in human renal allografts: preliminary report of a biopsy study.
    Bohman SO; Wilczek H; Jaremko G; Lundgren G
    Transplant Proc; 1984 Jun; 16(3):649-53. PubMed ID: 6375033
    [No Abstract]   [Full Text] [Related]  

  • 19. Glomerular and tubular basement membrane calcinosis: case report and literature review.
    Troxell ML; Higgins JP; Sibley RK
    Am J Kidney Dis; 2006 Feb; 47(2):e23-6. PubMed ID: 16431246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of glomerular basement membrane lesions in a male patient with Alport syndrome: ultrastructural and morphometric study.
    Cangiotti AM; Sessa A; Meroni M; Montironi R; Ragaiolo M; Mambelli V; Cinti S
    Nephrol Dial Transplant; 1996 Sep; 11(9):1829-34. PubMed ID: 8918631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.